Potato modified for increased sucrose synthesis | BCH-LMO-SCBD-111612 | Living Modified Organism | Biosafety Clearing-House

Loading...
Living Modified Organism (LMO)
  |  
BCH-LMO-SCBD-111612-1   |   PDF   |   Print   |  
Decisions on the LMO Risk Assessments  
last updated: 31 Jan 2017
Living Modified Organism identity
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.
Potato modified for increased sucrose synthesis
EN
5 independent lines
No
The genetically modified plants express the coding region of inorganic pyrophosphatase from Escherichia coli which is specifically expressed in photosyntetically active mesophyll cells.

As a result of the genetic modification the production of the heterologous pyrophosphatase leads to the removal of cytoplasmatic pyrophosphate which results in the preferential production of sucrose in the modified potato plants.
EN
The term “Recipient organism” refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas “Parental organisms” refers to those that were involved in cross breeding or cell fusion.
EN
Characteristics of the modification process
Derivative of pBIN19
EN
  • Agrobacterium-mediated DNA transfer
Some of these genetic elements may be present as fragments or truncated forms. Please see notes below, where applicable.
  • BCH-GENE-SCBD-111604-1 Fructose-1,6-bisphosphatase gene promoter | Solanum tuberosum (Potato, SOLTU)
    Promoter
  • BCH-GENE-SCBD-111605-1 Inorganic pyrophosphatase gene | Escherichia coli (ECOLX)
    Protein coding sequence | Changes in quality and/or metabolite content (Carbohydrates)
  • BCH-GENE-SCBD-100271-5 Octopine Synthase Gene Terminator | Agrobacterium tumefaciens (Agrobacterium)
    Terminator
  • BCH-GENE-SCBD-15001-5 Neomycin Phosphotransferase II | Escherichia coli (ECOLX)
    Protein coding sequence | Resistance to antibiotics (Kanamycin)
The neomycin phosphotransferase II of the Tn5 transposon is used as a selection marker.
EN
LMO characteristics
EN
  • Research
Detection method(s)
EN
Additional Information
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Living modified organism(s) 1
Risk Assessment generated by a regulatory process Living modified organism(s) 1